Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Nov 7, 2012 · 10-Q · 38 days after period end · 0001062822-12-000050
| Metric | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|
| Revenue | $372.00K | $355.00K | $781.00K |
| Net Income | -$29.54M | -$26.10M | -$27.51M |
| EPS Diluted | -$0.06 | -$0.08 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 7, 2012 · 38 d after period end
